RxDoctor Payments Data

Michelle Myers, PA

Physician Assistant · Akron, OHNPI 1962911032

Payments from drug & device makers

$952in general payments, 2019–2025

Across 36 payments — averaging $26.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$307
  • Abbott$149
  • Cvrx, Inc.$139
  • Boehringer Ingelheim$118
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$67
  • E.r. Squibb & Sons, L.L.C.$54
  • plus $118 from 5 others

What the payments were for

  • Food & beverage$952100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$952 in reported general payments places this provider in the 75th percentile of 4,098 physician assistant providers in Ohio.

See all physician assistant providers in Ohio

Medicare billing

Part B allowed, 2024
$19,136
Medicare patients
95
Services billed
215

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EntrestoSacubitril/Valsartan191$294,977
FarxigaDapagliflozin Propanediol150$184,011
EliquisApixaban112$158,624
JardianceEmpagliflozin104$142,736
XareltoRivaroxaban19$24,544
OzempicSemaglutide21$23,852
Metoprolol Succinate215$3,498
Torsemide141$3,105
Spironolactone263$1,802
Isosorbide Dinitrate17$1,286
Ezetimibe30$1,230
Hydralazine Hcl58$1,028
Amiodarone Hcl25$954
Bumetanide16$850
Rosuvastatin Calcium50$829

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
NovartisEntresto$48$294,977191 claims
AstraZenecaFarxiga$307$184,011150 claims
Boehringer IngelheimJardiance$118$142,736104 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 4,098 physician assistant providers in Ohio.

Other physician assistant in Akron

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →